ArticleFrontiers in oncology2022

Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy.

Xiguang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.